References
- Asero R, Tedeschi A, Lorini M, et al. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy. 2001;31:1105–1110.
- Chang TW, Chen C, Lin CJ, et al. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2015;135:337–342.
- Greaves MW. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–672.
- Fagiolo U, Cancian M, Bertollo L, et al. Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;103:1143–1147.
- Asero R, Tedeschi A, Riboldi P, et al. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol. 2006;117:1113–1117.
- Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol. 2007;119:705–710.
- Asero R, Tedeschi A, Riboldi P, et al. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy. 2008;63:176–180.
- Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 2010;65:649–656.
- Cugno M, Marzano AV, Tedeschi A, et al. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Clin Immunol. 2009;148:170–174.
- Puccetti A, Bason C, Simeoni ME, et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy. 2005;35:1599–1607.
- Kasperska-Zajac A, Brzoza Z. Increased D-dimer concentration in plasma of patients with severe acute urticaria. Br J Dermatol. 2009;161:1409–1410.
- Asero R. D-dimer: A biomarker for antihistamine-resistant chronic urticaria. J Allergy Clin Immunol. 2013;132:983–986.
- Asero R. Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria. J Allergy Clin Immunol. 2015;135:1401–1403.
- Marzano AV, Tedeschi A, Fanoni D, et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol. 2009;160:266–272.
- Cugno M, Cicardi M, Bottasso B, et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. 1997;89:3213–3218.
- Tedeschi A, Asero R, Marzano AV, et al. Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy. 2009;64:1616–1622.
- Tedeschi A, Asero R, Lorini M, et al. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy. 2010;40:875–881.
- Kasperska-Zajac A, Sztylc J, Machura E, et al. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41:1386–1391.
- Bossi F, Frossi B, Radillo O, et al. Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy. 2011;66:1538–1545.
- Grattan CE, Hamon CG, Cowan MA, et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol. 1988;119:179–183.